MEDICINOVA, INC.: 10-Q filed 2013-05-08

Name: MEDICINOVA, INC.: 10-Q filed 2013-05-08
Creator: MEDICINOVA, INC.

What MEDICINOVA, INC. reported in its quarterly report filed 2013-05-08 (fiscal Q1 2013): 33 published measures, 79 facts as tagged in accession 0001193125-13-207792.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-05-08
Fiscal period: fiscal Q1 2013
Accession: 0001193125-13-207792 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MEDICINOVA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-03-31	18,845,713	USD
At 2012-12-31	19,568,041	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-03-31	4,598,313	USD
At 2012-12-31	4,688,049	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-03-31	14,247,400	USD
At 2012-12-31	14,879,992	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-03-31	3,029,064	USD
At 2012-12-31	4,010,530	USD
At 2012-03-31	11,005,842	USD
At 2011-12-31	15,093,124	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	-2,419,014	USD	90
2000-10-01 to 2013-03-31	-267,289,689	USD	4565
2012-01-01 to 2012-03-31	-3,867,223	USD	91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	-2,621,901	USD	90
2000-10-01 to 2013-03-31	-212,334,372	USD	4565
2012-01-01 to 2012-03-31	-3,427,147	USD	91

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2000-10-01 to 2013-03-31	2,360,968	USD	4565
2012-01-01 to 2012-03-31	8,024	USD	91

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	3,257	USD	90
2000-10-01 to 2013-03-31	2,364,064	USD	4565
2012-01-01 to 2012-03-31	191,174	USD	91

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	1,635,635	USD	90
2000-10-01 to 2013-03-31	220,260,070	USD	4565
2012-01-01 to 2012-03-31	27,889	USD	91

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	4,800	USD	90
2000-10-01 to 2013-03-31	-4,896,634	USD	4565
2012-01-01 to 2012-03-31	-688,024	USD	91

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2013-03-31	-298,652,811	USD
At 2012-12-31	-296,233,797	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	-1,245	USD	90
2000-10-01 to 2013-03-31	74,716	USD	4565

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2013-03-31	69,906	USD
At 2012-12-31	78,474	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	157,700	USD	90
2000-10-01 to 2013-03-31	50,548,631	USD	4565
2012-01-01 to 2012-03-31	927,291	USD	91

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	-2,417,294	USD	90
2000-10-01 to 2013-03-31	-280,626,931	USD	4565
2012-01-01 to 2012-03-31	-3,873,259	USD	91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-03-31	3,712,646	USD
At 2012-12-31	4,422,122	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2000-10-01 to 2013-03-31	3,605,818	USD	4565

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-03-31	948,150	USD
At 2012-12-31	1,037,792	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2013-03-31	269,858	USD
At 2012-12-31	491,853	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2013-03-31	9,600,241	USD
At 2012-12-31	9,600,241	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	2,420,551	USD	90
2000-10-01 to 2013-03-31	282,990,995	USD	4565
2012-01-01 to 2012-03-31	4,064,433	USD	91

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2000-10-01 to 2013-03-31	1,258,421	USD	4565

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	695,972	USD	90
2000-10-01 to 2013-03-31	167,750,627	USD	4565
2012-01-01 to 2012-03-31	1,878,461	USD	91

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-03-31	18,260,569	shares
At 2012-12-31	17,403,125	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2013-03-31	314,079,009	USD
At 2012-12-31	312,293,225	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2013-03-31	-74,870	USD
At 2012-12-31	-67,957	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2013-03-31	431,959	USD
At 2012-12-31	314,652	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2013-03-31	683,582	USD
At 2012-12-31	411,592	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	-2,420,259	USD	90
2000-10-01 to 2013-03-31	-267,214,973	USD	4565
2012-01-01 to 2012-03-31	-3,867,223	USD	91

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	-2,419,014	USD	90
2000-10-01 to 2013-03-31	-298,652,811	USD	4565
2012-01-01 to 2012-03-31	-3,867,223	USD	91

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	1,724,579	USD	90
2000-10-01 to 2013-03-31	113,981,947	USD	4565
2012-01-01 to 2012-03-31	2,185,972	USD	91

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	33,567	USD	90
2000-10-01 to 2013-03-31	2,048,519	USD	4565
2012-01-01 to 2012-03-31	8,944	USD	91

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2013-01-01 to 2013-03-31	1,628,938	USD	90
2000-10-01 to 2013-03-31	134,294,163	USD	4565

Inspect the source

Entity: MEDICINOVA, INC. / CIK 0001226616
Captured: 2026-09-20T07:46:14.294Z
SEC response SHA-256: 2ee4e761c5c78942e5c8408ca3fc8acae481ff5fcfadf88ffba53700bd842714

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001226616.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))